Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated
thrombocytopenia and variable phenotype as some patients suffer no bleeding whilst others …

Platelets are essential for blood clotting and maintaining normal hemostasis. In pathological
conditions, platelets are increasingly recognized as crucial regulatory factors in various …

Cytochrome C (cyt C), the protein involved in oxidative phosphorylation, plays several other
crucial roles necessary for both cell life and death. Studying natural variants of cyt C offers …

Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a
reduction in platelet count due to autoantibody-mediated platelet destruction. ITP presents …

The pathogenesis of immune thrombocytopenia (ITP) is complex and involves the
dysregulation of immune cells, such as T and B lymphocytes, and several cytokines that …

Objectives: To investigate whether (cluster of differentiation) CD40‐1C> T (rs1883832)
contributes to predisposition and treatment response of primary immune thrombocytopenia …

Introduction This study aims to investigate the incidence, clinical characteristics, and
prognosis of thrombosis in Chinese patients with immune thrombocytopenia (ITP). Methods …

Immune thrombocytopenia (ITP) is an autoimmune disease associated with low platelets
and risk of bleeding. Standard-of-care treatment now includes the novel thrombopoietin …

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with a high incidence
of chronicity among adults. Rituximab is recommended as a treatment option for chronic ITP …

Disorders of blood coagulation can lead to manifest spontaneous bleeding and an
increased risk of bleeding during surgical procedures and interventions …